Compare EVOX & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVOX | SRZN |
|---|---|---|
| Founded | 2025 | 2015 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Blank Checks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.4M | 323.9M |
| IPO Year | N/A | N/A |
| Metric | EVOX | SRZN |
|---|---|---|
| Price | $9.99 | $30.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | 14.1K | ★ 98.6K |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $75.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.86 | $7.11 |
| 52 Week High | $10.09 | $33.22 |
| Indicator | EVOX | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 53.91 | 58.39 |
| Support Level | $9.98 | $23.95 |
| Resistance Level | $10.03 | N/A |
| Average True Range (ATR) | 0.01 | 2.20 |
| MACD | -0.00 | 0.35 |
| Stochastic Oscillator | 42.86 | 61.26 |
Evolution Global Acquisition Corp is a blank check company.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).